SCHOLAR ROCK HOLDING CORPORATION Increase (Decrease) in Other Noncurrent Assets
SCHOLAR ROCK HOLDING CORPORATION (SRRK) reported Increase (Decrease) in Other Noncurrent Assets of -$1.78 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-06
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$1.82M, a 1802.80% decline year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was $37.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$86.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was $353.00K, a 2841.67% increase year-over-year.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for fiscal 2025 was $286.00K.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for fiscal 2024 was -$1.47M, a 154.56% decline from fiscal 2023.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for fiscal 2023 was $2.70M, a 2681.44% increase from fiscal 2022.
- SCHOLAR ROCK HOLDING CORPORATION increase (decrease) in other noncurrent assets for fiscal 2022 was $97.00K, a 83.86% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets 3 month | Increase (Decrease) in Other Noncurrent Assets 6 month | Increase (Decrease) in Other Noncurrent Assets 9 month | Increase (Decrease) in Other Noncurrent Assets 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$1.82M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$1.78M 10-Q · filed 2026-08-06 | -$1.87M derived: sum of 3 quarters · filed 2026-08-06 | -$1.52M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $37.00K 10-Q · filed 2026-05-07 | -$49.00K derived: sum of 2 quarters · filed 2026-05-07 | $304.00K derived: sum of 3 quarters · filed 2026-05-07 | $411.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$86.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | $267.00K derived: sum of 2 quarters · filed 2026-03-03 | $374.00K derived: sum of 3 quarters · filed 2026-08-06 | $286.00K 10-K · filed 2026-03-03 |
| 2025-09-30 | $353.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $460.00K derived: sum of 2 quarters · filed 2026-08-06 | $372.00K 10-Q · filed 2025-11-14 | -$492.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $107.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $19.00K 10-Q · filed 2026-08-06 | -$845.00K derived: sum of 3 quarters · filed 2026-08-06 | -$833.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$88.00K 10-Q · filed 2026-05-07 | -$952.00K derived: sum of 2 quarters · filed 2026-05-07 | -$940.00K derived: sum of 3 quarters · filed 2026-05-07 | -$1.25M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$864.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | -$852.00K derived: sum of 2 quarters · filed 2026-03-03 | -$1.16M derived: sum of 3 quarters · filed 2026-03-03 | -$1.47M 10-K · filed 2026-03-03 |
| 2024-09-30 | $12.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | -$293.00K derived: sum of 2 quarters · filed 2025-11-14 | -$608.00K 10-Q · filed 2025-11-14 | $2.48M derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$305.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | -$620.00K 10-Q · filed 2025-08-06 | $2.46M derived: sum of 3 quarters · filed 2025-08-06 | $2.19M derived: sum of 4 quarters · filed 2025-08-06 |
| 2024-03-31 | -$315.00K 10-Q · filed 2025-05-14 | $2.77M derived: sum of 2 quarters · filed 2025-05-14 | $2.50M derived: sum of 3 quarters · filed 2025-05-14 | $2.45M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $3.08M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $2.81M derived: sum of 2 quarters · filed 2025-02-27 | $2.76M derived: sum of 3 quarters · filed 2025-02-27 | $2.70M 10-K · filed 2025-02-27 |
| 2023-09-30 | -$270.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$321.00K derived: sum of 2 quarters · filed 2024-11-12 | -$387.00K 10-Q · filed 2024-11-12 | -$400.00K derived: sum of 4 quarters · filed 2024-11-12 |
| 2023-06-30 | -$51.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | -$117.00K 10-Q · filed 2024-08-08 | -$130.00K derived: sum of 3 quarters · filed 2024-08-08 | -$82.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | -$66.00K 10-Q · filed 2024-05-07 | -$79.00K derived: sum of 2 quarters · filed 2024-05-07 | -$31.00K derived: sum of 3 quarters · filed 2024-05-07 | -$15.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | -$13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-19 | $35.00K derived: sum of 2 quarters · filed 2024-03-19 | $51.00K derived: sum of 3 quarters · filed 2024-03-19 | $97.00K 10-K · filed 2024-03-19 |
| 2022-09-30 | $48.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $64.00K derived: sum of 2 quarters · filed 2023-11-07 | $110.00K 10-Q · filed 2023-11-07 | $627.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $62.00K 10-Q · filed 2023-08-09 | $579.00K derived: sum of 3 quarters · filed 2023-08-09 | |
| 2022-03-31 | $46.00K 10-Q · filed 2023-05-09 | $563.00K derived: sum of 2 quarters · filed 2023-05-09 | ||
| 2021-12-31 | $517.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-07 | $601.00K 10-K · filed 2023-03-07 | ||
| 2021-09-30 | $84.00K 10-Q · filed 2022-11-14 | |||
| 2021-03-31 | -$25.00K 10-Q · filed 2022-05-16 | -$54.00K derived: sum of 2 quarters · filed 2022-05-16 | -$65.00K derived: sum of 3 quarters · filed 2022-05-16 | $166.00K derived: sum of 4 quarters · filed 2022-05-16 |
| 2020-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-07 | -$40.00K derived: sum of 2 quarters · filed 2022-03-07 | $191.00K derived: sum of 3 quarters · filed 2022-03-07 | $923.00K 10-K · filed 2022-03-07 |
| 2020-09-30 | -$11.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $220.00K derived: sum of 2 quarters · filed 2021-11-09 | $952.00K 10-Q · filed 2021-11-09 | $965.00K derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $231.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $963.00K 10-Q · filed 2021-08-10 | $976.00K derived: sum of 3 quarters · filed 2021-08-10 | |
| 2020-03-31 | $732.00K 10-Q · filed 2021-05-13 | $745.00K derived: sum of 2 quarters · filed 2021-05-13 | ||
| 2019-12-31 | $13.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-09 | $98.00K 10-K · filed 2021-03-09 | ||
| 2019-09-30 | $85.00K 10-Q · filed 2020-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| IOVANCE BIOTHERAPEUTICS, INC. (IOVA) | United States | $4.897B | -6.51 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |